The effects of the manipulation of 5-HT, DA and NA on exercise-induced fatigue and brain activation

Status

Not yet recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-514038-19-00

Enrollment

Registered

2024-08-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Brief summary

Physiological changes during the onset and impact of fatigue under influence of elevated brain neurotransmitters, Behavioral changes during the onset and impact of fatigue under influence of elevated brain neurotransmitters, Subjective changes during the onset and impact of fatigue under influence of elevated brain neurotransmitters

Interventions

DRUGEdronax 4 mg Tabletten

DRUGRilatine Modified Release 10 mg Hartkapseln mit veränderter Wirkstofffreisetzung

DRUGP-Tabletten weiß 7 mm Lichtenstein

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
Physiological changes during the onset and impact of fatigue under influence of elevated brain neurotransmitters, Behavioral changes during the onset and impact of fatigue under influence of elevated brain neurotransmitters, Subjective changes during the onset and impact of fatigue under influence of elevated brain neurotransmitters	—

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026